Probiotics and Wegovy: do they actually help?

No probiotic strain has been clinically proven to enhance semaglutide's weight-loss effect or prevent its gastrointestinal side effects.
Wegovy's most common side effects (nausea, diarrhoea, constipation) are GI-led and typically settle within the first few weeks at a new dose.
Gut microbiome research is genuinely active science, but the leap from "GLP-1 alters gut motility" to "take this probiotic" is not yet supported by randomised trial data in humans on semaglutide.
High-fibre, protein-adequate, minimally processed food has the strongest evidence for supporting gut health on any weight-management medicine.

If you're taking Wegovy and wondering whether adding a probiotic could ease nausea, settle your digestion or support weight loss further, you're asking a question our prescribers hear regularly. The honest answer: probiotics are not a proven add-on to semaglutide treatment, and no specific strain has been clinically established as the "best probiotic for Wegovy" — but the gut-health angle is worth understanding properly, because some of the reasoning people use is sound even when the conclusion gets ahead of the science. Wegovy is a prescription-only semaglutide injection that works on GLP-1 receptors to reduce appetite and slow gastric emptying; those same gut-physiology changes are why digestive questions come up so often. This page covers what is and isn't known, what a probiotic can and cannot do alongside treatment, and which dietary habits are better supported by evidence.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence says about probiotics, gut health and semaglutide

Does taking a probiotic help with Wegovy side effects like nausea and diarrhoea?

The gut-related side effects of semaglutide are real and, for some people, genuinely disruptive at first. Nausea, loose stools, constipation and bloating are the most frequently reported, and they tend to peak after starting treatment or stepping up to a higher dose. The NHS semaglutide patient information page notes that these effects are usually mild to moderate and tend to improve as your body adjusts — typically within days to a couple of weeks.

Probiotics are sometimes suggested as a way to cushion this adjustment. The logic is reasonable on the surface: if your gut is unsettled, live cultures that support microbial balance might help. The problem is that there is no clinical trial evidence, in people taking Wegovy specifically, showing that any probiotic strain (Lactobacillus, Bifidobacterium, Saccharomyces or otherwise) meaningfully reduces those side effects compared with placebo. Most of the trials that do support probiotics for antibiotic-associated diarrhoea or irritable bowel syndrome involve very different gut-disruption mechanisms.

That doesn't make probiotics harmful. For most healthy adults they are considered safe. But spending money on a supplement marketed with GLP-1 or semaglutide language, on the basis that it will ease Wegovy's side effects, is getting ahead of what the evidence can actually support right now. If side effects are severe or aren't settling, that's a conversation for your prescriber, not a job for a supplement.

Is there a link between GLP-1 medicines and the gut microbiome?

Yes, and it's a genuinely interesting area of research. GLP-1 receptors exist throughout the gut, and semaglutide's action on gastric emptying and intestinal transit does change the gut environment. Some early studies have observed shifts in microbiome composition in people on GLP-1 medicines, including changes in the relative abundance of certain bacterial families. Researchers are actively investigating whether those microbiome shifts contribute to the weight-loss effect, or whether they are simply a downstream consequence of eating less and eating differently.

What this research has not yet produced is a clear intervention: a specific strain, dose or formulation of probiotic that demonstrably improves outcomes for someone on semaglutide. The science is at the hypothesis-generating stage, not the clinical-recommendation stage. Anyone selling a probiotic with the explicit claim that it works synergistically with GLP-1 medication is outrunning the evidence.

What does have stronger backing is the diet-microbiome connection. Eating more fibre from vegetables, legumes and wholegrains, staying well hydrated, and not cutting food intake so low that beneficial bacteria are starved of substrate, these things matter for gut health regardless of whether you're on a weight-management medicine. Our page on what to eat on Wegovy covers the practical food choices that sit alongside treatment and are actually evidence-informed.

What should you actually look for in a probiotic if you still want to try one?

If you want to try a probiotic alongside Wegovy, there are some basic quality checks worth doing. A quick one you can do right now: look up the product on the manufacturer's website and check whether it lists the specific strain (genus, species and ideally strain code, for example, Lactobacillus rhamnosus GG rather than just "Lactobacillus"), the CFU count at the end of shelf life rather than at manufacture, and whether there is published human trial data for that exact strain and the health claim being made. If any of those three pieces of information are missing, the product is harder to evaluate.

Beyond that, general principles apply. Strains backed by the most human trial data (Lactobacillus rhamnosus GG, Bifidobacterium longum, Saccharomyces boulardii) have reasonable safety records and some evidence for general gut resilience, even if none of that evidence was generated in a semaglutide cohort. Storage matters too: many live cultures need refrigeration to maintain viability. Fermented foods like plain yogurt, kefir, sauerkraut and miso provide similar bacteria through diet, which is a cheaper and often more sustainable route.

Timing relative to your Wegovy dose is not a documented concern, semaglutide is a subcutaneous injection and doesn't interact with oral supplements through absorption the way some oral medicines do. That said, if you're also taking any oral medication, check with your prescriber, since Wegovy can slow gastric emptying and that does affect how quickly oral drugs are absorbed. This is one of several practical questions worth raising at your next clinical review.

What actually supports gut health on Wegovy, according to the evidence?

The most evidence-backed gut-health strategy on any weight-management medicine is straightforward: prioritise protein, eat enough fibre, stay hydrated, and avoid letting appetite suppression push your total intake so low that your diet becomes nutritionally thin. Semaglutide reduces hunger effectively (that's its job) but eating very little, especially low in fibre, can worsen constipation and reduce microbial diversity over time.

Aiming for 25–30g of fibre daily from whole foods is a reasonable target; the NHS healthy weight guidance supports this as part of a balanced diet. Meal planning on treatment is something many people find genuinely useful, and our Wegovy meal planning guide goes into practical detail on structuring meals when appetite is reduced. Protein shakes are sometimes helpful for people struggling with solid food at the start of treatment, and the guide to protein shakes on Wegovy covers what to look for.

On gut-motility specifically: gentle movement after meals, small and frequent meals rather than one large sitting, and reducing high-fat or very rich foods during the adjustment period are the practical steps our clinical team would discuss. These don't carry a product price tag. They do carry more evidence than any probiotic on the shelf currently marketed alongside GLP-1 medicines.

Wegovy is a prescription medicine requiring clinical assessment. If you are comparing your options and want to understand which site genuinely offers the best experience for getting Wegovy, or if you are trying to decide which place to buy Wegovy from with confidence, our guides walk through what to look for in a reputable provider. If you'd like to explore whether it's appropriate for you, you can check your eligibility through a free consultation with our GPhC-registered prescribers.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions